These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 228998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K.
    J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
    [Abstract] [Full Text] [Related]

  • 3. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Hashimoto's thyroiditis (author's transl)].
    Endo K.
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct 20; 55(10):1275-85. PubMed ID: 228999
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct 20; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H, Amino N, Watanabe Y, Aozasa M, Hayashi H, Tachi J, Miyai K.
    J Clin Lab Immunol; 1986 May 20; 20(1):1-6. PubMed ID: 3016274
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
    Docter R, Bos G, Visser TJ, Hennemann G.
    Clin Endocrinol (Oxf); 1980 Feb 20; 12(2):143-53. PubMed ID: 6105023
    [Abstract] [Full Text] [Related]

  • 10. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug 20; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 11. Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease.
    de Bruin TW, van der Heide D, Querido A, Krol MC.
    Clin Endocrinol (Oxf); 1984 Feb 20; 20(2):143-51. PubMed ID: 6325045
    [Abstract] [Full Text] [Related]

  • 12. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar 20; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan 20; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct 20; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 18. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Thyroidology; 1989 Apr 20; 1(1):31-7. PubMed ID: 2484905
    [Abstract] [Full Text] [Related]

  • 19. A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII).
    Bliddal H.
    Scand J Clin Lab Invest; 1981 Sep 20; 41(5):441-9. PubMed ID: 6118939
    [Abstract] [Full Text] [Related]

  • 20. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep 20; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.